Complement activation and cardiovascular disease

M Bjerre1, T K Hansen, A Flyvbjerg

  • 1The Medical Research Laboratories, Clinical Institute and Immunoendocrine Research Unit, Medical Department M (Diabetes and Endocrinology), Aarhus University Hospital, Aarhus C, Denmark. mette.bjerre@ki.au.dk

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|September 17, 2008
PubMed

Insights

Complement activation contributes to tissue damage after heart attacks. Targeting this system, particularly the lectin pathway, may offer new treatments for cardiovascular diseases and reperfusion injury.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pathophysiology

Background:

  • Tissue injury following acute myocardial infarction involves complex mechanisms.
  • Complement system activation is implicated in the pathophysiology of myocardial infarction and reperfusion injury.
  • While essential for immune defense, excessive complement activation can exacerbate tissue damage.

Purpose of the Study:

  • To review the role of complement activation in myocardial infarction and associated tissue injury.
  • To highlight the significance of the lectin pathway in cardiovascular diseases like ischemic heart disease and diabetic angiopathy.
  • To discuss potential therapeutic strategies targeting the complement system.

Main Methods:

  • Literature review focusing on complement activation, endothelial dysfunction, and cardiovascular diseases.
  • Analysis of the role of the lectin pathway in myocardial reperfusion injury.
  • Examination of therapeutic interventions targeting the complement cascade.

Main Results:

  • Complement activation plays a dual role, offering protection but also contributing to damage during myocardial reperfusion.
  • The lectin pathway is a key mediator in complement-induced cardiovascular pathology.
  • Endothelial dysfunction is closely linked to complement activation in cardiovascular diseases.

Conclusions:

  • Complement system modulation, especially the lectin pathway, presents a promising therapeutic avenue for myocardial infarction and related conditions.
  • Understanding complement's role is crucial for developing effective treatments for ischemic heart disease and diabetic angiopathy.
  • Targeting complement activation could mitigate reperfusion injury and improve patient outcomes.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...